Biotech: Pharma’s Reputation Saviour?

Biotech: Pharma’s Reputation Saviour?

Our recent pharma analysis concluded that journalists have started to report more favourably of pharma’s work and that companies are experiencing a reputational boost as the pandemic highlights their role in developing medications and vaccines. This comes at a time...
Pfizer: Corporate Reputation Analysis Case Study

Pfizer: Corporate Reputation Analysis Case Study

Not long ago, when a pharma company made headlines in the mainstream media, it was usually for all the wrong reasons – from the opioid crisis to high drug prices. We were so used to seeing the media demonise Big Pharma that it became common to...

Pin It on Pinterest